Neuropathic pain is one of the most complex and difficult to treat forms of chronic pain. It originates as peripheral or central nervous system disease or damage and can severely impact quality of life. The neuroinflammatory processes associated with this condition help to modify the sensory pain pathways and make them hypersensitive.

Our research into chronic neuropathic pain is exploring new strategies for modulating neuroinflammation and restoring pain circuit homeostasis. In this setting, ALIAmides offer new opportunities for managing complex and sometimes disabling diseases.